Altimmune to Announce Second Quarter 2021 Financial Results on August 11, 2021

GAITHERSBURG, Md., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2021 financial results on Wednesday, August 11, 2021.

Altimmune management will host a conference call for investors beginning at 8:30 am E.T. to discuss the second quarter 2021 financial results and provide a business update.

Conference Call Information:

About AltimmuneAltimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter

Investor and Media Contact:Will BrownChief Financial OfficerPhone: 240-654-1450[email protected]

You May Also Be Interested In

• Montis to present at the Blockchain & Digital Asset Virtual Investor Conference April 25th
• reMothering.org Announces the reMothering Masterclass Super-Summit: A Free Online Event to Deepen Self-Connection and Emotional Wellness
• Rater, the Anti-Catfishing Social App, Announces Launch Across the Nation